创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Immune Co-Culture Killing Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-17 15:06
  • Views:

(Summary description)With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.

InnoModels Biotechnology: Immune Co-Culture Killing Models

(Summary description)With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-17 15:06
  • Views:
Information

With the continuous development of biological science and medical technology, human understanding of diseases and treatment modalities are gradually deepening. Among them, immunotherapy, as an emerging therapeutic modality, has shown great potential in fields such as cancer. However, the mechanism of immunotherapy is complex, and how to accurately simulate the immune response process in the body has been a challenge for researchers. For this reason, InnoModels Biotechnology has developed a new 3D immune co-culture killing model, which aims to more realistically simulate the interaction between immune cells and tumor cells in the body, providing a more accurate tool for immunotherapy research.
1. 3D tissue simulation: restoring the real immune environment
Traditional immune models can only simulate simple cell-cell interactions, but cannot fully restore the complex immune environment in the body. The 3D immune co-culture killing model of InnoModels Biotechnology, however, constructs a more realistic 3D tissue structure through precise cell culture technology, which better simulates the complex interactions between immune cells and tumor cells in vivo. This three-dimensional structure not only provides a closer cell survival environment in vivo, but also simulates the spatial distribution and interaction between cells, making the experimental results more informative.
2、Multi-cell type participation: comprehensive simulation of immune response
Compared with traditional immune models, the 3D immune co-culture killing model of InnoModels Biotechnology is able to introduce a variety of immune cell types at the same time, such as natural killer cells (NK cells), T cells, etc. This involvement of multiple cell types makes it possible to simulate the immune response in a comprehensive way. This involvement of multiple cell types enables the model to simulate more complex immune response processes, and the experimental results are more biologically meaningful. In addition, this visualization also enables researchers to intuitively observe the killing process of immune cells, which helps to gain a deeper understanding of the mechanism of immunotherapy.

 


3、Application Prospects: Helping Immunotherapy Research
The 3D immune co-culture killing model of InnoModels provides strong support for immunotherapy research. Its accurate simulation of the interaction between immune cells and tumor cells in vivo enables researchers to more accurately predict the effects of therapeutic drugs in vivo. This is of great significance for optimizing treatment plans, improving treatment efficiency and reducing side effects. At the same time, the model also helps researchers gain a deeper understanding of the mechanism of immunotherapy, providing new ideas and methods for future immunotherapy.
In conclusion, the 3D immune co-culture killing model of InnoModels has revolutionized immunotherapy research. Its precise simulation of the in vivo immune environment, participation of multiple cell types, and visualization make immunotherapy research more in-depth and comprehensive. With the continuous development and improvement of this technology, it is believed that future immunotherapy will be more accurate and efficient, bringing hope to more patients.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司